Biomedical Research Company for Sale
Biomedical Research Institution with 75 Percent Profit Margin
On NextCompany since August 27, 2026 (48 days)
Location undisclosed
Business overview
A biomedical research institution delivers global genomic profiling and molecular diagnostics. It serves over 850 clients including academic centers and pharmaceutical companies. The lab holds CAP accreditation and CLIA licensing. Revenue averaged over $5,000,000 annually for 25 years. Net profit margin reached 75 percent. The owner pursues other ventures and offers transition assistance.
Who is a good fit for this business
- Buyers pursuing biomedical research institutions with high margins.
- Investors open to labs serving 850 clients globally.
- Acquirers who seek 75 percent net profit margins.
Details
- Reason for selling
- Owner is pursuing the sale to concentrate on other business ventures.
Frequently Asked Questions
The institution delivers global genomic profiling and molecular diagnostics. It operates in three research stages. Clients include academic centers and biotech firms.
The lab serves over 850 clients. It holds CAP accreditation and CLIA licensing. Revenue averaged over $5,000,000 for 25 years.
Net profit margin reached 75 percent. The owner pursues other ventures. Transition assistance is available.
The owner pursues other business ventures. The owner offers to remain during transition. The owner may stay as consultant if needed.